The NHS Children and Young People’s Gender Service (The Service) will provide care to children and young people who express gender incongruence and who are likely to benefit from clinical support, and ...
A new life-changing treatment option – GLP-1 drug semaglutide known as Wegovy – is set to be available on the NHS within months, with 1.2 million people with cardiovascular disease eligible to receive ...
This is a livestream recording of the NHS England board meeting that took place on 26 March 2026. This recording can be made available in a different format on request. Please contact us ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results